Yu Lin

No.399 In Wanyuan Road
Shanghai, 201102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Application of Total-Body PET in Pediatric Patients.

Application of Total-Body PET in Pediatric Patients.

Journal: PET clinics

Published: November 25, 2025

Exploring the feasibility of a 40-minute uptake time for long axial field of view [18F]FDG PET/CT tumour scan: an evidence-based single-center study.

Exploring the feasibility of a 40-minute uptake time for long axial field of view [18F]FDG PET/CT tumour scan: an evidence-based single-center study.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 06, 2025

Benefits of high-normal-dose 18 F-fluorodeoxyglucose PET/computed tomography imaging: a comparative study in total-body and short axial field-of-view PET/computed tomography systems.

Benefits of high-normal-dose 18 F-fluorodeoxyglucose PET/computed tomography imaging: a comparative study in total-body and short axial field-of-view PET/computed tomography systems.

Journal: Nuclear medicine communications

Published: January 14, 2025

Dual-Time-Point 18F-FDG PET/CT in a case of primary hepatic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Dual-Time-Point 18F-FDG PET/CT in a case of primary hepatic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: October 13, 2024

[18F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study.

[18F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 09, 2024

Clinical Explorations of [68Ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.

Clinical Explorations of [68Ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.

Journal: Seminars in nuclear medicine

Published: September 22, 2024

Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

Journal: Therapeutic advances in medical oncology

Published: July 29, 2024

68Ga-FAPI and 18F-FDG PET images in a patient with tuberculosis mimicking malignant tumor on CT.

68Ga-FAPI and 18F-FDG PET images in a patient with tuberculosis mimicking malignant tumor on CT.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: August 01, 2023

The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study.

The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study.

Journal: European radiology

Published: December 28, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026